A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
242 patients (121 patients in each of the two treatment arms) will be included with a confirmed diagnosis of HIV-1 infection and with a stable antiretroviral treatment during more than 48 weeks with dual therapy (DTG + 3TC)
Epistemonikos ID: 95b76e3111189cdc16b710c9a81caf165f109f01
First added on: May 22, 2024